Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Investigating the Advantages of a Bank account: A Complete Aide - 2Support Your Body: A Manual for Smart dieting and Sustenance
- 3Comet C/2025 K1 (ATLAS) breaks apart in incredible telescope photos
- 4Rescuers again fail to free whale stranded on Germany's Baltic coast
- 5Language Learning Applications for Voyagers
- Figure out How to Recognize Early Indications of Depressions
- Brazil's ex-president Bolsonaro operated on for hernia
- Washington resident is infected with a different type of bird flu
- Santa's sleigh or the International Space Station? How to spot a bright Christmas flyby Dec. 24 and 25
- Bayer sues COVID vaccine makers over mRNA technology
- Figure out How to Stay away from Normal Handshaking Missteps
- Car Investigation: A Survey of \Past the Outside\ Car
- Swap The Amalfi Coast For This Low-Cost Ligurian Seaside Town
- Warship sunk by British fleet, remains of sailor found after 225 years
